Invention Grant
- Patent Title: Synthesis of omecamtiv mecarbil
-
Application No.: US17324867Application Date: 2021-05-19
-
Publication No.: US11753394B2Publication Date: 2023-09-12
- Inventor: Sebastien Caille , Kyle Quasdorf , Philipp C. Roosen , Xianqing Shi , Andrew Cosbie , Fang Wang , Zufan Wu , Archana Neergunda , Bin Peter Quan , Lianxiu Guan
- Applicant: AMGEN INC.
- Applicant Address: US CA Thousand Oaks
- Assignee: AMGEN INC.
- Current Assignee: AMGEN INC.
- Current Assignee Address: US CA Thousand Oaks
- Agency: Morrison & Foerster LLP
- The original application number of the division: US16607940
- Main IPC: C07D401/12
- IPC: C07D401/12 ; C07D241/04
Abstract:
Provided herein is a synthesis for omecamtiv mecarbil dihydrochloride hydrate and various intermediates.
Public/Granted literature
- US20210371397A1 SYNTHESIS OF OMECAMTIV MECARBIL Public/Granted day:2021-12-02
Information query
